
How Trump’s tariffs could upend pharma’s overseas tax strategy
That revelation was part of a Senate Finance Committee investigation done by Democratic staff, released in March, that examined how U.S. pharmaceutical giants exploit a loophole created by the 2017 Trump tax overhaul to shift profits offshore. The strategy …